Drug
BV100 clinical trials
Also written BV100.
- studies test it
- 9
- open now
- 2
- in phase 3
- 1
- first study started
- 2020
Keep track of what changes. Save the BV100 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BV100 is read from its arms, and is right about nine times in ten.
Testing it · 9
- A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy VolunteersRecruitingPhase 1BioVersys SASNCT07580586Written as BV100 (300 mg)
- Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus ComplexRecruitingPhase 3BioVersys SASNCT07326540Written as BV100 (300 mg)
- A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic ImpairmentCompletedPhase 1BioVersys AGNCT05537142Written as BV100
- Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100CompletedPhase 1BioVersys AGNCT05684705Written as BV100
- To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100CompletedPhase 1BioVersys AGNCT05684718Written as BV100 (300 mg)
- A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy ParticipantsCompletedPhase 1BioVersys AGNCT05537090Written as BV100
- Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal ImpairmentCompletedPhase 1BioVersys AGNCT05086107Written as BV100
- Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male SubjectsCompletedPhase 1BioVersys SASNCT05087069Written as BV100
- Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male SubjectsCompletedPhase 1BioVersys SASNCT04636983Written as BV100